EUR 4.3 million for new biomarker development center
Validation for Alzheimer’s Disease, COPD and Type-2 Diabetes
The Dutch Technology Foundation (STW) and seven industrial partners have awarded EUR 4.3 million to form the Biomarker Development Center, a public-private partnership to accelerate the validation and development of biomarkers. The center will focus on the development and validation of already identified biomarkers in three disease areas: Alzheimer’s Disease, COPD and Type-2 Diabetes.
Prof. Rainer Bischoff of the Analytical Biochemistry group, University of Groningen, will lead the project together with colleagues from the Radboud University Medical Center in Nijmegen, the Erasmus Medical Center in Rotterdam and the University Medical Center Groningen.
Validating for Alzheimer’s Disease, COPD and Type-2 Diabetes
The Biomarker Development Center will not focus on the discovery of novel biomarkers, but on the validation and development of already identified biomarkers following a rigorous selection from public and proprietary sources. Through a matrix structure, three biomarker validation technologies (high throughput sample preparation, high-sensitivity LC-MS/MS and ultrasensitive immunoassays) will be applied in three disease areas: Alzheimer’s Disease, COPD and Type-2 Diabetes.
Partnership researchers and industries
The funds are obtained from STW, part of the Dutch Organization for Scientific Research (NOW), combined with contributions by seven participating industrial partners of which TNO acts as independent data capture and analysis partner. Application of the output is ensured by the clinicians involved who will select and co-develop the candidate biomarkers, ensuring direct implementation in their patient care, whereas the industrial partners are first in line to commercialize the outcomes of the program.
Topsector Life Science & Health
The project objective originated from the alignment of public-private interests in the Topsector Life Science & Health, where accelerated biomarker development was identified as key factor to stimulate innovation in molecular diagnostics and personalized healthcare. Rainer Bischoff: "This grant for the Biomarker Development Center is an important first step towards further integrated biomarker research and development projects, particularly aiming at pharmaceutical industries and European funding.”
Last modified: | 07 August 2020 11.47 a.m. |
More news
-
29 April 2024
Tactile sensors
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
29 April 2024
Behind the scenes: how UG and Hanze UAS students are jointly developing a Mars rover
This year the students of the Makercie team are participating in the physical edition of the European Rover Challenge in Poland. Read more about the team and the collaboration between the RUG and Hanze UAS here.
-
23 April 2024
Nine MSCA Doctoral Network grants for FSE researchers
Nine researchers of the Faculty of Science and Engineering have received a Horizon Europe Marie Sklodowska Curie Doctoral Network grant.